Inactive

At the request of Argonne, The Contractor will screen 100 compounds in 7 colorectal cancer (CRC) models including 2 cancer cell lines and 5 patient-derived organoid (PDO) models. Data generated throug... At the request of Argonne, The Contractor will screen 100 compounds in 7 colorectal cancer (CRC) models including 2 cancer cell lines and 5 patient-derived organoid (PDO) models. Data generated through the experiments will be provided to Argonne. The generated data will be used to evaluate (1) the qualification of The Contractor as a potential vendor for a large-scale drug screening study in near future and (2) the feasibility of using the data for evaluating existing drug response prediction models. Please review the Statement of Work, Instructions for Offerors, and award documentation included in the Attachments field of this solicitation for more detailed requirements. If able to provide this service, please complete and return all required documentation and information to mmurtaugh@anl.gov by 12:00pm CDT, 08/11/2023.